Codex consultations on Food information: how can technology reinforce food allergy patients’ safety
At a time of increased integration of digital technology in all aspects of life, food information is just another field expected to go through...
Food labelling in online grocery shopping: allergy patients respond to Codex e-commerce guidance
Grocery e-commerce has been selling more and more prepacked food in the past years. In 2023, the Codex Committee on Food Labelling (CCFL) has launched...
EFA participates in the Codex Alimentarius Commission revision consultations of the General Standard for the Labelling of Prepacked Food (GSLPF)
In 2022-2023, EFA has participated in a consultation process organised by the Codex Alimentarius Commission (CAC), a WHO-FAO body setting international...
EU tobacco and smoking legislation review delayed, despite urgent update is needed
Since May 2022, the Commission has launched the evaluation process of the Tobacco Products Directive (TPD) and the Tobacco Advertising Directive (TAD)....
EFA appointed at the newly-launched WHO Civil Society Commission
EFA has been selected as a member of the newly-established WHO’s Civil Society Commission (CSC), to contribute to the WHO’s initiative of deepening...
EFA brings chronic respiratory disease patients’ perspectives to the NCD discussions at the European Parliament
EFA co-authors the recommendations of the Partnership for Health System Sustainability and Resilience (PHSSR) new report on Non-Communicable Diseases...
EFA participates in two European Commission consultations on the upcoming EU HTA Regulation implementation
EFA participates in two European Commission consultations on the upcoming EU HTA Regulation implementation
Since its set up in June 2023, the European...
EFA brought the voice of allergy, asthma and COPD patients in the meeting of the 73rd WHO Regional Committee for Europe in Astana
On October 24-26, EFA participated in the 73th meeting of the WHO Regional Committee for Europe, that took place in Astana, Kazakhstan. It was the 73rd...
EFA cosigned paper on the future of HERA
In November, the Civil Society Forum (CSF) of the European Commission’s Health Emergency Preparedness and Response Authority (HERA) adopted its first...
Revision of EU air quality laws in search of urgency and ambition: EFA at the 4th EU CleanAirForum
EFA travelled to Rotterdam (the Netherlands), to bring to the EU Clean Air Forum the perspective of allergy, asthma and COPD patients, at a crucial...
EFA responds to European Commission final consultations on the EU pharmaceutical legislation proposals
In November 2023, EFA responded to the European Commission final consultations on the much-awaited proposals for the revision of the EU general...
EU is scanning technologies for better Indoor Air Quality during pandemics
In November 2023, EFA participated in a full day workshop in Brussels to explore technologies for mitigating the transmission of airborne pathogens. At...
Health organisations urge EU member states to adopt their clean air negotiating position
In view of ongoing deliberations on the revision of the EU’s Ambient Air Quality Directive (AAQD), health organisations representing...
Capacity Building: First EFA sponsored advocates graduate as EUPATI Patients Experts
As part of the EFA Capacity Building 2022-2023, two EFA members completed the EUPATI Patient Expert Training Programme and graduated on the 26th of October...
Recording out! Webinar 'Sharing is Caring: Exchanging Knowledge on Asthma Care'
Watch the replay of our webinar and learn more about how information on asthma care can become more accessible. We presented a new educational...
EFA co-signs EADV Call to Action on chronic inflammatory skin disease
The European Academy for Dermatology and Venerology launched October 2023 a European call to action to drive positive change for chronic...
EFA calls on better care for atopic eczema patients at the EADV 2023
EFA presents highlights of the Atopic Eczema Consensus Europe Report at the EADV 2023 and calls on European policymakers to address the burden of atopic...
EFA organises the first SynAir-G workshop in Montpellier on the impact of indoor air pollutants on child health
EFA organises the first-ever SynAir-G hybrid workshop on the impact of indoor air pollutants on childhood health, highlighting the perspective of patients...
TOLIFE: mission and achievements of the Patient Advisory Group (PAG) in the first year of the project
EFA joins TOLIFE partners in Barcelona to celebrate the first year of the project, highlighting important milestones of the Patient Advisory Group...
EFA submits respiratory patients’ considerations to ECHA draft restriction on PFAS
Source: European Chemicals Agency (ECHA)
This week EFA participated in the European Chemicals Agency (ECHA) consultation on the proposal for the restriction...